METTL14 and colorectal carcinoma: In CRC, METTL14 promotes the degradation of SRY-related high-mobility group box 4 (SOX4) in an m6A-dependent way, triggering the inhibition of metastasis of CRC via phosphatidylinositol 3-kinase (PI3K)/Akt signal [82].